Papillary serous carcinoma of the ovary following prolonged tamoxifen treatment

We present a patient with breast cancer who developed papillary serous adenocarcinoma of the ovary after 13 years of tamoxifen use. The possible association is explored and the literature is reviewed.

Saved in:
Bibliographic Details
Published inEuropean journal of gynaecological oncology Vol. 20; no. 3; p. 237
Main Authors Seoud, M, Salem, Z, Shamseddine, A, Khabbaz, A, Zaatari, G, Khalil, A
Format Journal Article
LanguageEnglish
Published Italy 1999
Subjects
Aged
Breast Neoplasms - drug therapy
Cystadenocarcinoma, Papillary - chemically induced
Estrogen Antagonists - adverse effects
Female
Humans
Ovarian Neoplasms - chemically induced
Tamoxifen - adverse effects
Online AccessGet more information

Cover

More Information
Summary:We present a patient with breast cancer who developed papillary serous adenocarcinoma of the ovary after 13 years of tamoxifen use. The possible association is explored and the literature is reviewed.
ISSN:0392-2936